Description
Cell line name NCC-MFS2-C1
Accession CVCL_A2EI
Resource Identification Initiative To cite this cell line use: NCC-MFS2-C1 (RRID:CVCL_A2EI)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 13 hours (PubMed=32870449).
Omics: SNP array analysis.
Derived from site: In situ; Thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
Disease Myxofibrosarcoma (NCIt: C6496)
Myxofibrosarcoma (ORDO: Orphanet_79105)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 71Y
Category Cancer cell line
STR profile
Source(s): PubMed=32870449
Markers:
Amelogenin | X,Y |
CSF1PO | 12 |
D5S818 | 11,12 |
D7S820 | 9,12 |
D13S317 | 9,11 |
D16S539 | 9,12 |
D21S11 | 30 |
TH01 | 6 |
TPOX | 11,12 |
vWA | 14,17 |
Publications
PubMed=32870449; DOI=10.1007/s13577-020-00420-z
Noguchi R., Yoshimatsu Y., Ono T., Sei A., Hirabayashi K., Ozawa I., Kikuta K., Kondo T.
Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma.
Hum. Cell 34:246-253(2021)
Cross-references
Encyclopedic resources Wikidata; Q105510292
Reviews
There are no reviews yet.